Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews

Abstract

Rationale

The interaction between two non-psychotropic cannabinoids, cannabidiol (CBD) and cannabigerol (CBG), which have been reported to act as a 5-hydroxytryptamine 1A (5-HT1A) agonist and antagonist, respectively, was evaluated.

Objective

To evaluate the potential of CBG to reverse the anti-nausea, anti-emetic effects of CBD.

Materials and methods

In experiment 1, rats were pre-treated with CBG (0.0, 1, 5, and 10 mg/kg, ip), 15 min prior to being treated with CBD (experiment 1a: VEH or 5 mg/kg, ip) or 8-OH-DPAT (experiment 1b: VEH or 0.01 mg/kg, ip). Thirty minutes later, all rats received a pairing of 0.1% saccharin solution and LiCl (20 ml/kg of 0.15 M, ip). Seventy-two hours later, the rats received a drug-free taste reactivity test with saccharin to evaluate the effects of the treatments on the establishment of conditioned gaping reactions (a model of nausea). As well, conditioned saccharin avoidance was measured. In experiment 2, Suncus murinus were injected with CBG (5 mg/kg, ip) or VEH 15 min prior to CBD (5 mg/kg) or VEH and 30 min later were injected with LiCl (60 ml/kg of 0.15 M, i.p.), and the number of vomiting episodes were measured.

Results

CBD (5 mg/kg) suppressed conditioned gaping in rats and vomiting in shrews, which were reversed by pre-treatment with all doses of CBG. CBG also prevented the anti-nausea effects of 8-OH-DPAT.

Conclusions

Interactions between moderate doses of CBG and CBD may oppose one another at the 5-HT1A receptor in the regulation of nausea and vomiting.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Abrahamov A, Abrahamov A, Mechoulam R (1995) An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci 56:2097–2102

    PubMed  Article  CAS  Google Scholar 

  2. Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Starvi M et al (2008) Antibacterial cannabinoids from Cannabis sativa: a structure–activity study. J Nat Prod 71:1427–1430

    PubMed  Article  CAS  Google Scholar 

  3. Breslin PAS, Grill HJ, Spector AC (1992) A quantitative comparison of taste reactivity behaviors to sucrose before and after lithium chloride pairings: a unidimensional account of palatability. Behav Neurosci 106:820–836

    PubMed  Article  CAS  Google Scholar 

  4. Cascio MG, Gauson LA, Ross RA, Pertwee RG (2010) Evidence that the plant cannabionoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br J Pharmacol 159:129–141

    PubMed  Article  CAS  Google Scholar 

  5. Colasanti BK (1990) A comparison of the ocular and central effects of delta-9-tetrahydrocannabinol and cannabigerol. J Ocular Pharmacol Ther 6:259–269

    Article  CAS  Google Scholar 

  6. Colasanti BK, Craig CR, Allara RD (1984) Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol and cannabigerol. Exper Eye Res 39:251–259

    Article  CAS  Google Scholar 

  7. Darmani NA (2001) Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptor in the least shrew. Pharmacol Biochem Behav 69:239–249

    PubMed  Article  CAS  Google Scholar 

  8. Darmani NA, Janoyan JJ, Crim J, Ramirez J (2007) Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew. Eur J Pharmacol 563:187–196

    PubMed  Article  CAS  Google Scholar 

  9. De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P et al (2008) Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and malastatin type-8. J Pharmacol Exp Ther 325:1007–1015

    PubMed  Article  Google Scholar 

  10. Eisohly HN, Turner CE, Clark AM, Eisohly MA (2006) Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds. J Pharm Sci 71:1319–1323

    Article  Google Scholar 

  11. Gaoni Y, Mechoulam R (1964a) Isolation, structure, and partial synthesis of an active component of hashish. J Amer Chem Soc 86:1646–1647

    Article  CAS  Google Scholar 

  12. Gaoni Y, Mechoulam R (1964b) The structure and synthesis of cannabigerol, a new hashish constituent. Proc Chem Soc 82

  13. Grill HC, Norgren R (1978) The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats. Brain Res 143:263–279

    PubMed  Article  CAS  Google Scholar 

  14. Hayakawa K, Mishima K, Abe K, Hasebe N, Takamatsu F, Yasuda H et al (2004) Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism. NeuroReport 15:2381–2385

    PubMed  Article  CAS  Google Scholar 

  15. Kwiatkowska M, Parker LA, Burton P, Mechoulam R (2004) A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). Psychopharmacol 174:254–259

    CAS  Google Scholar 

  16. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L et al (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318:1375–1387

    PubMed  Article  CAS  Google Scholar 

  17. Limebeer CL, Parker LA (1999) Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea. NeuroReport 10:3769–3772

    PubMed  Article  CAS  Google Scholar 

  18. Limebeer CL, Parker LA (2003) The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats. Psychopharmacol 166:120–126

    CAS  Google Scholar 

  19. Limebeer CL, Vemuri VK, Bedard H, Lang ST, Ossenkopp KP, Makriyannis A, Parker LA (2010) Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats. Br J Pharm (in press)

  20. Lucot JB, Crampton GH (1988) 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin, or xylazine. Pharmacol Biochem Behav 33:627–632

    Article  Google Scholar 

  21. Maor Y, Morowitz M, Gallily R, Mechoulam R (2005) Cannabigerol-dimethyl heptyl (CBG-DMH), a synthetic cannabinoid with hypotensive and vasorelaxant properties. Presented at the symposium of the International Cannabinoid Research Society, Clearwater, FL, June

  22. Mechoulam R (1970) Marihuana chemistry. Science 168:1159–1163

    PubMed  Article  CAS  Google Scholar 

  23. Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42:11S–19S

    PubMed  CAS  Google Scholar 

  24. Mechoulam R, Peters M, Murillo-Rodriquez E, Hanus LO (2007) Cannabidiol—recent advances. Chem Biodiv 4:1678–1692

    Article  CAS  Google Scholar 

  25. Mehmedic Z, Chandra S, Slade D, Denham H, Foster S, Patel AS, Ross SA, Khan IA, ElSohly MA (2010) Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993–2008. J Forensic Sci 55:1209–1217

    PubMed  Article  CAS  Google Scholar 

  26. Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K et al (2005) Cannabidiol prevents infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36:1071–1076

    Article  CAS  Google Scholar 

  27. Orr LE, McKernan JF, Bloome B (1980) Antiemetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Arch Intern Med 140:1431–1433

    PubMed  Article  CAS  Google Scholar 

  28. Parker LA, Limebeer CL (2008) Cannabinoids and the management of nausea and vomiting. In: Kofalvi A (ed) Cannabinoids and the brain. Springer, New York

    Google Scholar 

  29. Parker LA, Mechoulam R (2003) Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats. Integr Phsyiol Behav Sci 38:133–145

    Article  Google Scholar 

  30. Parker LA, Mechoulam R, Schlievert C (2002) Cannabidiol, a non-psychoactive component of cannabis, and its dimethylheptyl homolog suppress nausea in an experimental model with rats. NeuroReport 13:567–570

    PubMed  Article  CAS  Google Scholar 

  31. Parker LA, Mechoulam R, Schlievert C, Abbott L, Fudge ML, Burton P (2003) Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea. Psychopharmacol 166:156–162

    CAS  Google Scholar 

  32. Parker LA, Kwiatkowska M, Burton P, Mechoulam R (2004) Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus. Psychopharmacol 171:156–161

    Article  CAS  Google Scholar 

  33. Parker LA, Limebeer CL, Kwiatkowska M (2005) Cannabinoids: effects on vomiting and nausea in animal models. In: Mechoulam R (ed) Cannabinoids as therapeutics. Birkhäuser, Switzerland, pp 183–200

    Google Scholar 

  34. Parker LA, Kwiatkowska M, Mechoulam R (2006) Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: an animal model of anticipatory nausea and vomiting. Physiol Behav 87:61–71

    Article  Google Scholar 

  35. Parker LA, Limebeer CL, Rana SA (2008) Conditioned nausea in rats: assessment by conditioned disgust reactions, rather than conditioned taste avoidance. Can J Exp Psychol 62:189–209

    Google Scholar 

  36. Parker, LA., Limebeer CL, Rock EM, Litt DL, Kwiatkowska M., and Piomelli D. (2009) The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine- induced vomiting in the Suncus murinus (house musk shrew). Physiol Behav 97: 121-124

    Google Scholar 

  37. Pertwee RG (2004) In: DiMarzo V (ed) The pharmacology and therapeutic potential of cannabidiol, in cannabinoids. Kluwer, New York

    Google Scholar 

  38. Rock EM, Limebeer CL, Mechoulam R, Piomelli D, Parker LA (2008) The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat. Psychopharmacol 196:389–395

    Article  CAS  Google Scholar 

  39. Rock EM, Limebeer CL, Fletcher PJ, Mechoulam R, Parker LA (2010). Cannabidiol (the non-psychoactive component of cannabis) may act as a 5-HT1A auto-receptor agonist to reduce toxin-induced nausea and vomiting. Poster presented at the Society for Neuroscience meeting, San Diego, CA

  40. Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1A receptors. Neurochem Res 30:1037–1043

    PubMed  Article  CAS  Google Scholar 

  41. Sallan SE, Zinberg NE, Frei E (1975) Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. New Engl J Med 293:795–797

    PubMed  Article  CAS  Google Scholar 

  42. Tramer MR, Carroll D, Campbell FA, Reynolds DJM, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:1–8

    Article  Google Scholar 

  43. Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS et al (2001) Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterol 121:767–774

    Article  Google Scholar 

  44. Wilkinson JD, Williamson EM (2007) Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have potential therapeutic value in the treatment of psoriasis. J Dermatol Sci 45:87–92

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgements

The following research was supported by research grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada to LAP, a scholarship from NSERC to EMR, and a grant from NIDA (9789) to RM and RGP. For reprints please contact parkerl@uoguelph.ca.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Linda A. Parker.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rock, E.M., Goodwin, J.M., Limebeer, C.L. et al. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology 215, 505–512 (2011). https://doi.org/10.1007/s00213-010-2157-4

Download citation

Keywords

  • Nausea
  • Vomiting
  • Cannabinoids
  • Cannabigerol
  • Cannabidiol
  • Serotonin
  • 5-HT1A
  • Phytocannabinoid